Replies to post #583 on Bristol Myers Squibb (BMY)

[Johnny_C]

I was talking to a friend last night at a function. Oncology is making the most strides it ever has.

The treatments are becoming more and more customizable to specific cancers and specific areas, so this is certainly good news.

Fast Track also allows piecemeal submissions and a quicker turn around once the NDA is submitted so it is all good.

Just the fact that the FDA acknowledges that this is a needed drug is very positive.